BDBM645539 2-{[2-(4-{2-[(4-{[6-(5-chloro- 2-fluorophenyl)pyridazin-4- yl]amino}quinolin-7-yl)oxy]- ethyl}piperazin-1-yl)ethyl]- (2-hydroxyethyl)amino}ethan- 1-ol::US20240018122, Example 75

SMILES OCCN(CCO)CCN1CCN(CCOc2ccc3c(Nc4cnnc(c4)-c4cc(Cl)ccc4F)ccnc3c2)CC1

InChI Key InChIKey=UDCXSIWGTZGVLS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 645539   

TargetTGF-beta receptor type-1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645539(US20240018122, Example 75 | 2-{[2-(4-{2-[(4-{[6-(5...)
Affinity DataIC50: 1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
US Patent